Welcome!

News Feed Item

Understanding and Tackling Prostate and Colorectal Cancer Through Unlocking the Cancer's DNA Code

LEIDEN, The Netherlands, February 27, 2014 /PRNewswire/ --

With a large contribution of the Center for Translational Molecular Medicine (CTMM), a new Dutch consortium will study the relationship between DNA aberrations and the development of both prostate and colorectal tumours. The project application has been filed by the Erasmus Medical Center, ServiceXS B.V. and the VU University Medical Center and will be coordinated by professor Guido Jenster (Erasmus MC). They have received funding of 1 million euros for this project called "NGS-ProToCol".

Cancer and DNA

Cancer is a disease of the DNA, caused by changes in the genome of normal cells, resulting in cancer cells with the ability to continuously grow and to respond variably on anticancer treatments. In order to understand why normal cells become cancer cells and how we can identify and destroy them, the researchers in this project want to uncover all the DNA changes in a large set of individual tumors. Particularly for common tumor types such as prostate and colorectal cancers the researchers hope to make a serious impact and improve diagnosis, prognosis and treatment.

Recent developments in the area of genome sequencing (also called next-generation sequencing) make it possible to discover all mutations in a tumour in a single experiment. By analyzing the genome and transcriptome of multiple prostate and colorectal tumours, the researchers expect to discover and validate markers useful for finding tumors in an early stage and for predicting the aggressiveness of the disease. In addition, the genomic information will result in the identification of novel cancer proteins for which new therapeutic drugs can be designed.

Website: http://www.ctmm.nl/en/projecten/translational-research-it-trait/ngs-protocol


Background information NGS ProToCol

The study project has been named NGS-ProToCol and aligns well with the expertise and the ambitions of the Erasmus MC and VUmc in the field of cancer research and that of ServiceXS in the area of genome and transcriptome analyses. The researchers at the Erasmus MC will study in prostate tumours how DNA mutations will influence the nature of the tumour, whereas VUmc will perform similar analyses in colorectal tumours. Being a pioneer in the area of genome sequencing, ServiceXS will perform the DNA and RNA sequencing experiments. The researchers expect to be able to come with results within 2 years.

NGS-ProToCol extends the genomic work initiated by two other CTMM projects: Prostate Cancer Molecular Medicine (PCMM; coordinated by Prof. dr. Chris Bangma, Erasmus MC) and Decrease Colorectal cancer Death (DeCoDe; coordinated by Prof. dr. Gerrit Meijer, VUmc). Within these consortia, DNA and RNA analyses already identified candidate biomarkers that with next-generation sequencing technologies will be validated in NGS-ProToCol. In addition, the challenging and complex workflows for NGS data management and data processing will be captured and made publicly available through a third CTMM project, TRAnslational research IT (TraIT; coordinated by Prof. dr. Gerrit Meijer, VUmc).    

About CTMM

The CTMM (Center for Translational Molecular Medicine) is a Netherlands-based public-private partnership. It is dedicated to the development of technologies in molecular medicine that enable early diagnosis and personalized treatment for main areas of disease causing mortality and diminished quality of life in the western world. Focus lies on oncology, cardiovascular, neurodegenerative and infectious/auto-immune disease. CTMM operates by inviting, assessing and funding multidisciplinary projects that involve active participation by Netherlands-based academia and industry. All CTMM projects are judged by an independent International Advisory Board and approved by a Supervisory Board based on their significant potential to translate research knowledge into clinical practice. The CTMM is funded by the Dutch government (50%), academia (25%) and industry (25%). Additional funding is provided by supporting foundations on behalf of patients.

Key figures CTMM: 122 partners, M€ 302.7 allocated budget until the end of 2015, 25 projects/consortia

http://www.ctmm.nl

About Erasmus MC and VUmc

As centres of medical innovation, the Erasmus Medical Center (Erasmus MC) and VU University Medical Center (VUmc) play an (inter)nationally recognized leading role in cancer research. The core tasks of the both centers are research, education, patient care and training. Both hospitals are part of the Dutch Federation of University Medical Centers (NFU). The NFU is a cooperation of the eight University Medical Centers in the Netherlands.

http://www.erasmusmc.nl

http://www.vumc.nl

About ServiceXS B.V.

ServiceXS is a service company in the area of molecular genetics and is based in Leiden, The Netherlands. In 2006 ServiceXS was the first company in Europe to offer next-generation sequencing services. Recently, ServiceXS was the first service provider world-wide to acquire Ion-Proton equipment, which offers new possibilities for whole-genome genetic analysis and will be used for this first Dutch large-scale cancer genetics project.

http://www.servicexs.com

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
As software becomes more and more complex, we, as software developers, have been splitting up our code into smaller and smaller components. This is also true for the environment in which we run our code: going from bare metal, to VMs to the modern-day Cloud Native world of containers, schedulers and micro services. While we have figured out how to run containerized applications in the cloud using schedulers, we've yet to come up with a good solution to bridge the gap between getting your contain...
The modern software development landscape consists of best practices and tools that allow teams to deliver software in a near-continuous manner. By adopting a culture of automation, measurement and sharing, the time to ship code has been greatly reduced, allowing for shorter release cycles and quicker feedback from customers and users. Still, with all of these tools and methods, how can teams stay on top of what is taking place across their infrastructure and codebase? Hopping between services a...
Niagara Networks exhibited at the 19th International Cloud Expo, which took place at the Santa Clara Convention Center in Santa Clara, CA, in November 2016. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
Zerto exhibited at SYS-CON's 18th International Cloud Expo®, which took place at the Javits Center in New York City, NY, in June 2016. Zerto is committed to keeping enterprise and cloud IT running 24/7 by providing innovative, simple, reliable and scalable business continuity software solutions. Through the Zerto Cloud Continuity Platform™, organizations can seamlessly move and protect virtualized workloads between public, private and hybrid clouds. The company’s flagship product, Zerto Virtual...
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
WebRTC is about the data channel as much as about video and audio conferencing. However, basically all commercial WebRTC applications have been built with a focus on audio and video. The handling of “data” has been limited to text chat and file download – all other data sharing seems to end with screensharing. What is holding back a more intensive use of peer-to-peer data? In her session at @ThingsExpo, Dr Silvia Pfeiffer, WebRTC Applications Team Lead at National ICT Australia, looked at differ...
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
SYS-CON Events announced today that CA Technologies has been named "Platinum Sponsor" of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and 21st International Cloud Expo, which will take place in November in Silicon Valley, California.
The security needs of IoT environments require a strong, proven approach to maintain security, trust and privacy in their ecosystem. Assurance and protection of device identity, secure data encryption and authentication are the key security challenges organizations are trying to address when integrating IoT devices. This holds true for IoT applications in a wide range of industries, for example, healthcare, consumer devices, and manufacturing. In his session at @ThingsExpo, Lancen LaChance, vic...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...